A major source of genetic heterogeneity is derived from single base-pair alterations in the DNA sequence. The presence of these single-nucleotide polymorphisms can be measured and analyzed, and can potentially be used, therefore, to investigate genetic heterogeneity, to identify disease-associated variants and, in the future, to develop tailored clinical approaches for individual patients with rheumatic diseases.